These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16400291)

  • 1. Guidelines for new antiepileptic drug evaluation.
    Hixson JD; French JA
    Rev Neurol Dis; 2004; 1 Suppl 1():S18-26. PubMed ID: 16400291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy in children and infants.
    Wilfong AA
    Neurology; 2007 Dec; 69(24 Suppl 3):S17-22. PubMed ID: 18071153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: II. Chronic therapy with antiepileptic drugs in adults and in children].
    Sánchez-Alvarez JC; Galán-Barranco JM; Camino-León R; Pita-Calandre E; Ramos-Lizana J; Moreno-Alegre V; Rufo-Campos M; Mercadé-Cerdá JM; Casado-Chocán JL; Altuzarra-Corral A; Serrano-Castro PJ;
    Rev Neurol; 2005 May 16-31; 40(10):619-25. PubMed ID: 15926137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drugs: from scientific evidence to clinical practice.
    García-Morales I; Sancho Rieger J; Gil-Nagel A; Herranz Fernández JL
    Neurologist; 2007 Nov; 13(6 Suppl 1):S20-8. PubMed ID: 18090948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dilemmas of contemporary epilepsy pharmacotherapy].
    Bielen I
    Acta Med Croatica; 2005; 59(1):1-6. PubMed ID: 15813349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy clinical trial design.
    Sachdeo R
    Neurology; 2007 Dec; 69(24 Suppl 3):S23-7. PubMed ID: 18071154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy.
    Azar NJ; Abou-Khalil BW
    Semin Neurol; 2008 Jul; 28(3):305-16. PubMed ID: 18777477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of standard and new antiepileptic drugs.
    Devinsky O; Cramer J
    Neurology; 2000; 55(11 Suppl 3):S5-10. PubMed ID: 11147569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiepileptic agents.
    Nelson LP; Savelli-Castillo I
    Pediatr Dent; 2004; 26(1):58-62. PubMed ID: 15080360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic medications for the treatment of epilepsy.
    Morrell MJ
    Semin Neurol; 2002 Sep; 22(3):247-58. PubMed ID: 12528050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for novel antiepileptic drugs.
    Avanzini G; Franceschetti S
    Curr Opin Investig Drugs; 2003 Jul; 4(7):805-14. PubMed ID: 14619401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new look at the second-generation antiepileptic drugs: a decade of experience.
    LaRoche SM
    Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
    Legros B; Boon P; Dejonghe P; Sadzot B; Van Rijckevorsel K; Schmedding E
    Acta Neurol Scand; 2007 Feb; 115(2):97-103. PubMed ID: 17212612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: I. Criteria for starting and discontinuing and the pharmacological bases of antiepileptic treatment].
    Serrano-Castro PJ; Ramos-Lizana J; Pita-Calandre E; Camino-León R; Galán-Barranco JM; Rufo-Campos M; Moreno-Alegre V; Altuzarra-Corral A; Casado-Chocán JL; Mercadá-Cerdá JM; Sánchez-Alvarez JC
    Rev Neurol; 2005 May 1-15; 40(9):563-71. PubMed ID: 15898019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the response to antiepileptic drugs: effect of past treatment history.
    Schiller Y; Najjar Y
    Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obtaining pediatric indications for new anti-epileptic drugs: how and when.
    Garofalo E
    Epilepsy Res; 2006 Jan; 68(1):38-42. PubMed ID: 16377135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.
    Arts WF; Geerts AT
    Eur J Paediatr Neurol; 2009 Mar; 13(2):93-101. PubMed ID: 18567515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines--are they useful?
    Ben-Menachem E; French JA
    Epilepsia; 2006; 47 Suppl 1():62-4. PubMed ID: 17044829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.